LACK OF METHYLATION OF INORGANIC ARSENIC IN THE CHIMPANZEE

被引:88
作者
VAHTER, M
COUCH, R
NERMELL, B
NILSSON, R
机构
[1] COULSTON FDN,WHITE SANDS RES CTR,ALAMOGORDO,NM 88310
[2] UNIV STOCKHOLM,WALLENBERG LAB,DEPT GENET & CELLULAR TOXICOL,S-10691 STOCKHOLM,SWEDEN
关键词
D O I
10.1006/taap.1995.1150
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Most mammals methylate inorganic arsenic (As) to methylarsonic acid (MMA) and dimethylarsinic acid, which are rapidly excreted in the urine. Previous studies have shown that, in contrast to humans, all experimental animals excrete very little MMA. With the aim of finding an appropriate animal model for studies on inorganic As metabolism and toxicity, we have investigated the metabolism of As in two male chimpanzees after a single iv dose of[As-73]arsenate (5.8 mu g As/kg body wt). The initial clearance from plasma was rapid with an apparent half-time of about 1 hr. Urine was found to constitute the major excretory pathway with very little excretion in the feces. About 60% of the administered As-73 dose was excreted in the urine within 96 hr in a biphasic manner. The second phase of slow urinary excretion was characterized by first-order kinetics with a half-time of about 7 days. Upon ion-exchange chromatography of ultrafiltrated plasma and urine, only inorganic As could be detected, a finding confirmed by thin-layer chromatography. Thus, the results indicate that the chimpanzee, as previously shown for the marmoset monkey, but unlike all other mammals studied so far, including humans, is unable to methylate and detoxify inorganic As. (C) 1995 Academic Press, Inc.
引用
收藏
页码:262 / 268
页数:7
相关论文
共 43 条
[21]   A RAPID METHOD FOR THE SELECTIVE ANALYSIS OF TOTAL URINARY METABOLITES OF INORGANIC ARSENIC [J].
NORIN, H ;
VAHTER, M .
SCANDINAVIAN JOURNAL OF WORK ENVIRONMENT & HEALTH, 1981, 7 (01) :38-44
[22]   BIOMETHYLATION OF INORGANIC ARSENIC BY THE RAT AND SOME LABORATORY-ANIMALS [J].
ODANAKA, Y ;
MATANO, O ;
GOTO, S .
BULLETIN OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY, 1980, 24 (03) :452-459
[23]  
POMROY C, 1980, TOXICOL APPL PHARM, V53, P550, DOI 10.1016/0041-008X(80)90368-3
[24]  
STEVENS JT, 1977, ENVIRON HEALTH PERSP, V19, P151, DOI 10.2307/3428468
[25]   METABOLISM OF INORGANIC ARSENIC (AS-74) IN HUMANS FOLLOWING ORAL INGESTION [J].
TAM, GKH ;
CHARBONNEAU, SM ;
BRYCE, F ;
POMROY, C ;
SANDI, E .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1979, 50 (02) :319-322
[26]   SEPARATION OF ARSENIC METABOLITES IN DOG PLASMA AND URINE FOLLOWING INTRAVENOUS-INJECTION OF AS-74 [J].
TAM, KH ;
CHARBONNEAU, SM ;
BRYCE, F ;
LACROIX, G .
ANALYTICAL BIOCHEMISTRY, 1978, 86 (02) :505-511
[27]   BIOTRANSFORMATION OF TRIVALENT AND PENTAVALENT INORGANIC ARSENIC IN MICE AND RATS [J].
VAHTER, M .
ENVIRONMENTAL RESEARCH, 1981, 25 (02) :286-293
[28]   TISSUE DISTRIBUTION AND RETENTION OF AS-74-DIMETHYLARSINIC ACID IN MICE AND RATS [J].
VAHTER, M ;
MARAFANTE, E ;
DENCKER, L .
ARCHIVES OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY, 1984, 13 (03) :259-264
[29]   METABOLISM OF ARSENOBETAINE IN MICE, RATS AND RABBITS [J].
VAHTER, M ;
MARAFANTE, E ;
DENCKER, L .
SCIENCE OF THE TOTAL ENVIRONMENT, 1983, 30 (SEP) :197-211
[30]   CONCENTRATIONS OF ARSENIC IN URINE OF THE GENERAL-POPULATION IN SWEDEN [J].
VAHTER, M ;
LIND, B .
SCIENCE OF THE TOTAL ENVIRONMENT, 1986, 54 :1-12